Evidence map›Paper›PMID 24188171›Full record

ArticleExperimental and clinical psychopharmacology2014

The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults.

Olivia M Farr, Sien Hu, David Matuskey, Sheng Zhang, Osama Abdelghany, Chiang-Shan R Li

Open access · greenAbstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Catecholaminergic Modulation of Conflict Control Depends on the Source of Conflicts.The international journal of neuropsychopharmacology · 2018
    Trial
  3. Waiting Impulsivity: The Influence of Acute Methylphenidate and Feedback.The international journal of neuropsychopharmacology · 2015
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Methylphenidate Modulates Functional Network Connectivity to Enhance Attention.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Olivia M FarrInterdepartmental Neuroscience Program, Yale University School of Medicine.
Sien HuDepartment of Psychiatry, Yale University School of Medicine.
David MatuskeyDepartment of Psychiatry, Yale University School of Medicine.
Sheng ZhangDepartment of Psychiatry, Yale University School of Medicine.
Osama AbdelghanyInvestigational Drug Service, Yale New Haven Hospital.
Chiang-Shan R LiInterdepartmental Neuroscience Program, Department of Psychiatry, Yale University School of Medicine.
Yale University · USYale New Haven Hospital · US

Funding

NEUROBIOLOGY OF CORTICAL SYSTEMST32NS007224 · NINDS · YALE UNIVERSITY · PI CARDIN, JESSICA A · 1985 to 2025
$4.6M
Cognitive control and cocaine dependence: thalamic noradrenergic processesR01DA023248 · NIDA · YALE UNIVERSITY · PI LI, CHIANG-SHAN RAY · 2008 to 2018
$4.0M
Translational Research of Cocaine, Striatum, and ImpulsivitiesP20DA027844 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2010 to 2013
$3.6M
Cerebral Correlates of Early Habitual DrinkingR01AA021449 · NIAAA · YALE UNIVERSITY · PI LI, CHIANG-SHAN RAY · 2013 to 2017
$1.2M
Imaging Cognitive Control in Cocaine DependenceK02DA026990 · NIDA · YALE UNIVERSITY · PI LI, CHIANG-SHAN RAY · 2009 to 2013
$639k
Amygdala Processes and Early Habitual DrinkingR21AA018004 · NIAAA · YALE UNIVERSITY · PI LI, CHIANG-SHAN RAY · 2009 to 2010
$383k
Thalamic Processes of Self Control in Cocaine DependenceR21DA026998 · NIDA · YALE UNIVERSITY · PI LI, CHIANG-SHAN RAY · 2009 to 2010
$373k
NIAAA NIH HHS R01 AA021449NIAAA NIH HHS R21 AA018004NIAAA NIH HHS R21AA018004NIDA NIH HHS K02 DA026990NIDA NIH HHS K02DA026990NIDA NIH HHS P20 DA027844NIDA NIH HHS P20DA027844NIDA NIH HHS R01 DA023248NIDA NIH HHS R01DA023248NIDA NIH HHS R21 DA026998NINDS NIH HHS T32 NS007224NINDS NIH HHS T32 NS07224
6 · The paper itself

Abstract

Detection of a salient stimulus is critical to cognitive functioning. A stimulus is salient when it appears infrequently, carries high motivational value, and/or when it dictates changes in behavior. Individuals with neurological conditions that implicate altered catecholaminergic signaling, such as those with attention deficit hyperactivity disorder, are impaired in detecting salient stimuli, a deficit that can be remediated by catecholaminergic medications. However, the effects of these catecholaminergic agents on cerebral activities during saliency processing within the context of the stop-signal task are not clear. Here, we examined the effects of a single oral dose (45 mg) of methylphenidate in 24 healthy adults performing the stop-signal task during functional MRI (fMRI). Compared to 92 demographically matched adults who did not receive any medications, the methylphenidate group showed higher activations in bilateral caudate head, primary motor cortex, and the right inferior parietal cortex during stop as compared to go trials (p < .05, corrected for family-wise error of multiple comparisons). These results show that methylphenidate enhances saliency processing by promoting specific cerebral regional activities. These findings may suggest a neural basis for catecholaminergic treatment of attention disorders.

Indexed as

AdultBrainCentral Nervous System StimulantsFemaleHealthy VolunteersHumansMagnetic Resonance ImagingMaleMethylphenidateReaction TimeYoung AdultCentral Nervous System StimulantsMethylphenidate

Identifiers

PMID24188171
PMCPMC4105943
OpenAlexW2162555052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.